Status | Study |
Active, not recruiting |
Study Name: Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors Condition: Ewing's Sarcoma Osteosarcoma Astrocytoma Date: 2011-04-06 Interventions: Drug: sirolimus daily administration of sirolimus in oral form starting at a dose of 1 mg/m2 and increas |
Active, not recruiting |
Study Name: Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia Condition: Hepatoblastoma Previously Treated Childhood Rhabdomyosarcoma Date: 2010-06-30 Interventions: Drug: Alisertib Given orally |
Completed |
Study Name: A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB Condition: Medulloblastoma Rhabdomyosarcoma Neuroblastoma Date: 2010-05-12 Interventions: Drug: LDE225 LDE225/sonidegib capsules were supplied to the Investigators at dose strengths of 50 mg, 10 |
Recruiting |
Study Name: Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Condition: PRETEXT Stage 1 Hepatoblastoma PRETEXT Stage 2 Date: 2009-09-18 Interventions: Drug: Cisplatin Given IV |
Completed |
Study Name: Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors Condition: Adult Rhabdomyosarcoma Adult Synovial Sarcoma Childhood Date: 2009-01-28 Interventions: Biological: cixutumumab Given |
Active, not recruiting |
Study Name: Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy Condition: Brain Tumor Central Nervous System Tumor Childhood Germ Ce Date: 2008-07-15 Interventions: Drug: sodium thiosulfate Given |
Not yet recruiting |
Study Name: Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, Stage II, or Stage III Childhood Liver Cancer Condition: Liver Cancer Ototoxicity Date: 2008-04-02 Interventions: Drug: cisplatin Drug: sodium thiosulfate |
Recruiting |
Study Name: Irinotecan in Treating Young Patients With Refractory or Recurrent Hepatoblastoma Condition: Liver Cancer Date: 2006-02-06 Interventions: Drug: irinotecan hydrochloride |
Withdrawn |
Study Name: Hepatoblastoma Biology Study and Tissue Bank Condition: Hepatoblastoma Date: 2005-09-27 Interventions: Procedure: Biology Study and Tissue Banking Collection of specimens from Hepatoblastoma patients. |
Active, not recruiting |
Study Name: Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors Condition: Ewing's Sarcoma Soft Tissue Sarcoma Date: 2005-09-10 Interventions: Drug: High-Dose Chemotherapy with Tandem PBSC Rescue. Patients on this study will undergo a tandem Perip |